Affiliations 

  • 1 Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia, Selangor Darul Ehsan, Malaysia ; Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
  • 2 Laboratory of Molecular Biomedicine, Universiti Putra Malaysia, Selangor Darul Ehsan, Malaysia ; Faculty of Pharmacy, Isra University, Amman, Jordan
  • 3 Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt ; Beckman Research Institute of City of Hope, Duarte, CA, USA
  • 4 Department of Bioengineering, Northeastern University, Boston, MA, USA ; Department of Chemical Engineering, Northeastern University, Boston, MA, USA
  • 5 Department of Chemical Engineering, Northeastern University, Boston, MA, USA ; Center of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia
  • 6 Materials Synthesis and Characterization Laboratory, Institute of Advanced Technology; Universiti Putra Malaysia, Selangor Darul Ehsan, Malaysia
Int J Nanomedicine, 2015;10:3269-74.
PMID: 25995633 DOI: 10.2147/IJN.S74469

Abstract

Magnetic nanoparticles (MNPs) were synthesized by the coprecipitation of Fe(2+) and Fe(3+) iron salts in alkali media. MNPs were coated by chitosan (CS) to produce CS-MNPs. Streptomycin (Strep) was loaded onto the surface of CS-MNPs to form a Strep-CS-MNP nanocomposite. MNPs, CS-MNPs, and the nanocomposites were subsequently characterized using X-ray diffraction and were evaluated for their antibacterial activity. The antimicrobial activity of the as-synthesized nanoparticles was evaluated using different Gram-positive and Gram-negative bacteria, as well as Mycobacterium tuberculosis. For the first time, it was found that the nanoparticles showed antimicrobial activities against the tested microorganisms (albeit with a more pronounced effect against Gram-negative than Gram-positive bacteria), and thus, should be further studied as a novel nano-antibiotic for numerous antimicrobial and antituberculosis applications. Moreover, since these nanoparticle bacteria fighters are magnetic, one can easily envision magnetic field direction of these nanoparticles to fight unwanted microorganism presence on demand. Due to the ability of magnetic nanoparticles to increase the sensitivity of imaging modalities (such as magnetic resonance imaging), these novel nanoparticles can also be used to diagnose the presence of such microorganisms. In summary, although requiring further investigation, this study introduces for the first time a new type of magnetic nanoparticle with microorganism theranostic properties as a potential tool to both diagnose and treat diverse microbial and tuberculosis infections.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.